BACKGROUND: The etiology of lymphedema is multifactorial, and definition criteria of lymphedema, its limitation, and follow-up must be considered in studies related to risk factors. The aim of this study is to evaluate risk factors related to arm lymphedema in a cohort study with a long follow-up. PATIENTS AND METHODS: The study was performed in 622 breast cancer patients. The main endpoint reported was the presence of clinical lymphedema reported in medical records. Univariate and multivariate regression analyses were performed to identify factors related to lymphedema. RESULTS: 66.4% of the patients were submitted to mastectomy, 88.4% to level III axillary lymphadenectomy, 34.9% to radiotherapy in the supraclavicular fossa, and 4.3% to axillary radiotherapy. The mean follow-up was 96.7 months. 45 patients (7.2%) developed lymphedema, of which 82.2% had developed lymphedema at 60 months. Univariate regression analysis showed that supraclavicular radiotherapy, adjuvant/palliative chemotherapy, ≥ 15 lymph nodes dissected, and axillary surgery increase the lymphedema rate by 1.87, 2.28, 2.03, and 6.17, respectively. Adjusted multivariate regression analysis showed that the combination of axillary dissection and number of lymph nodes dissected was the main factor related to lymphedema (p = 0.017). CONCLUSION: In the pre-sentinel era, axillary dissection and the number of lymph nodes resected are related to 10-year lymphedema.
BACKGROUND: The etiology of lymphedema is multifactorial, and definition criteria of lymphedema, its limitation, and follow-up must be considered in studies related to risk factors. The aim of this study is to evaluate risk factors related to arm lymphedema in a cohort study with a long follow-up. PATIENTS AND METHODS: The study was performed in 622 breast cancerpatients. The main endpoint reported was the presence of clinical lymphedema reported in medical records. Univariate and multivariate regression analyses were performed to identify factors related to lymphedema. RESULTS: 66.4% of the patients were submitted to mastectomy, 88.4% to level III axillary lymphadenectomy, 34.9% to radiotherapy in the supraclavicular fossa, and 4.3% to axillary radiotherapy. The mean follow-up was 96.7 months. 45 patients (7.2%) developed lymphedema, of which 82.2% had developed lymphedema at 60 months. Univariate regression analysis showed that supraclavicular radiotherapy, adjuvant/palliative chemotherapy, ≥ 15 lymph nodes dissected, and axillary surgery increase the lymphedema rate by 1.87, 2.28, 2.03, and 6.17, respectively. Adjusted multivariate regression analysis showed that the combination of axillary dissection and number of lymph nodes dissected was the main factor related to lymphedema (p = 0.017). CONCLUSION: In the pre-sentinel era, axillary dissection and the number of lymph nodes resected are related to 10-year lymphedema.
Entities:
Keywords:
Breast cancer; Lymph node dissection; Lymphedema; Radiotherapy; Risk factors
Authors: J M Ververs; R M Roumen; A J Vingerhoets; G Vreugdenhil; J W Coebergh; M A Crommelin; E J Luiten; O J Repelaer van Driel; M Schijven; J C Wissing; A C Voogd Journal: Eur J Cancer Date: 2001-05 Impact factor: 9.162
Authors: Pedro E R Liedke; Dianne M Finkelstein; Jackie Szymonifka; Carlos H Barrios; Yanin Chavarri-Guerra; José Bines; Cláudia Vasconcelos; Sérgio D Simon; Paul E Goss Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-10-28 Impact factor: 4.254
Authors: Shelly B Hayes; Gary M Freedman; Tianyu Li; Penny R Anderson; Eric Ross Journal: Int J Radiat Oncol Biol Phys Date: 2008-12-01 Impact factor: 7.038
Authors: Idam de Oliveira-Junior; Eliana Aguiar Petri Nahas; Ana Cristina Cherem; Jorge Nahas-Neto; René Aloisio da Costa Vieira Journal: Breast Care (Basel) Date: 2020-03-27 Impact factor: 2.860
Authors: Eduardo Camargo Millen; Francisco Pimentel Cavalcante; Felipe Zerwes; Guilherme Novita; Alessandra Borba Anton de Souza; João Henrique Penna Reis; Helio Rubens de Oliveira Filho; Luciana Naíra de B L Limongi; Barbara Pace Silva de Assis Carvalho; Adriana Magalhães de Oliveira Freitas; Monica Travassos Jourdan; Vilmar Marques de Oliveira; Ruffo Freitas-Junior Journal: Ann Surg Oncol Date: 2021-09-27 Impact factor: 5.344
Authors: Almir Jose Sarri; Eduardo Tinois da Silva; Rene Aloisio da Costa Vieira; Katia Hiromoto Koga; Pedro Henrique Moriguchi Cação; Vitor Coca Sarri; Sonia Marta Moriguchi Journal: Breast Cancer (Dove Med Press) Date: 2017-04-19
Authors: Mario Marx; Michael Geßner; Alexander Florek; Susanne Morgenstern; Stefan Passin; Sara Y Brucker; Diethelm Wallwiener; Markus Hahn Journal: Geburtshilfe Frauenheilkd Date: 2020-05-18 Impact factor: 2.915